(Q40687177)

22 September 2017

title

Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients (English)

1 reference

22 September 2017

main subject

chronic myeloid leukemia

0 references

5

Champlin R

1 reference

22 September 2017

8

Arlinghaus RB

1 reference

22 September 2017

Guo JQ

1

1 reference

22 September 2017

Lin H

2

1 reference

22 September 2017

Kantarjian H

3

1 reference

22 September 2017

Talpaz M

4

1 reference

22 September 2017

Andreeff M

6

1 reference

22 September 2017

Glassman A

7

1 reference

22 September 2017

language of work or name

1 reference

1 December 2002

1 reference

22 September 2017

number of pages

7

1 reference

inferred from page(s)

published in

Leukemia

1 reference

22 September 2017

volume

16

1 reference

22 September 2017

issue

12

1 reference

22 September 2017

page(s)

2447-2453

1 reference

The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Minimal Residual Disease after Bone Marrow Transplant for Chronic Myeloid Leukaemia Detected by the Polymerase Chain Reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Detection and quantification of residual disease in chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402730

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402730

1 reference

Dimensions Publication ID

22 September 2017

1041038408

0 references

1 reference